Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study

Christiaan M. de Bloeme, Robin W. Jansen, Liesbeth Cardoen, Sophia Göricke, Sabien van Elst, Jaime Lyn Jessen, Aparna Ramasubramanian, Alison H. Skalet, Audra K. Miller, Philippe Maeder, Ogul E. Uner, G. Baker Hubbard, Hans Grossniklaus, H. Culver Boldt, Kim E. Nichols, Rachel C. Brennan, Saugata Sen, Mériam Koob, Selma Sirin, Hervé J. Brisse, Paolo Galluzzi, Charlotte J. Dommering, Matthijs Cysouw, Ronald Boellaard, Josephine C. Dorsman, Annette C. Moll, Marcus C. de Jong, Pim de Graaf, Unknown

Open source

DOI
10.1038/s41598-024-76933-6
Published
2024-10-23
Container
Scientific Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-024-76933-6,
  title = {Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study},
  author = {Christiaan M. de Bloeme and Robin W. Jansen and Liesbeth Cardoen and Sophia Göricke and Sabien van Elst and Jaime Lyn Jessen and Aparna Ramasubramanian and Alison H. Skalet and Audra K. Miller and Philippe Maeder and Ogul E. Uner and G. Baker Hubbard and Hans Grossniklaus and H. Culver Boldt and Kim E. Nichols and Rachel C. Brennan and Saugata Sen and Mériam Koob and Selma Sirin and Hervé J. Brisse and Paolo Galluzzi and Charlotte J. Dommering and Matthijs Cysouw and Ronald Boellaard and Josephine C. Dorsman and Annette C. Moll and Marcus C. de Jong and Pim de Graaf and Unknown},
  year = {2024},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-024-76933-6},
  url = {https://doi.org/10.1038/s41598-024-76933-6}
}

RIS

TY  - JOUR
TI  - Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study
AU  - Christiaan M. de Bloeme
AU  - Robin W. Jansen
AU  - Liesbeth Cardoen
AU  - Sophia Göricke
AU  - Sabien van Elst
AU  - Jaime Lyn Jessen
AU  - Aparna Ramasubramanian
AU  - Alison H. Skalet
AU  - Audra K. Miller
AU  - Philippe Maeder
AU  - Ogul E. Uner
AU  - G. Baker Hubbard
AU  - Hans Grossniklaus
AU  - H. Culver Boldt
AU  - Kim E. Nichols
AU  - Rachel C. Brennan
AU  - Saugata Sen
AU  - Mériam Koob
AU  - Selma Sirin
AU  - Hervé J. Brisse
AU  - Paolo Galluzzi
AU  - Charlotte J. Dommering
AU  - Matthijs Cysouw
AU  - Ronald Boellaard
AU  - Josephine C. Dorsman
AU  - Annette C. Moll
AU  - Marcus C. de Jong
AU  - Pim de Graaf
AU  - Unknown
PY  - 2024
JO  - Scientific Reports
DO  - 10.1038/s41598-024-76933-6
UR  - https://doi.org/10.1038/s41598-024-76933-6
ER  - 

APA

Bloeme, C. M. D., Jansen, R. W., Cardoen, L., Göricke, S., Elst, S. V., Jessen, J. L., Ramasubramanian, A., Skalet, A. H., Miller, A. K., Maeder, P., Uner, O. E., Hubbard, G. B., Grossniklaus, H., Boldt, H. C., Nichols, K. E., Brennan, R. C., Sen, S., Koob, M., Sirin, S., Brisse, H. J., Galluzzi, P., Dommering, C. J., Cysouw, M., Boellaard, R., Dorsman, J. C., Moll, A. C., Jong, M. C. D., Graaf, P. D., & Unknown (2024). Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case–control study. Scientific Reports. https://doi.org/10.1038/s41598-024-76933-6

Source records